BTIG downgraded iCAD (ICAD) to Neutral from Buy without a price target after the company announced it will be acquired by DeepHealth, a subsidiary of traded RadNet (RDNT) (RNDT).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICAD: